FORMULATION, OPTIMIZATION, CHARACTERIZATION AND IN VIVO ANTI-ULCER ACTIVITY OF ESOMEPRAZOLE MAGNESIUM TRIHYDRATE GASTRORESISTANT MICROSPHERES
Keywords:Gastroresistant, Microspheres, Design of experiment, Factorial design, HPMC acetate succinate, Ulcer-index
Objective: The objective of the present investigation was to prepare gastro-resistant microspheres of esomeprazole magnesium trihydrate (EMT) to prevent its degradation in the acidic environment of the stomach and enhance its bioavailability via intestinal absorption.
Methods: EMT loaded gastro-resistant microspheres were prepared using hypromellose acetate succinate (HPMCAS) as the gastro-resistant polymer by â€˜non-aqueous solvent evaporation' technique. A 3-factor 3 level factorial design was used to optimise EMT: HPMCAS ratio, the concentration of Span 80 and stirring speed with respect to percent entrapment efficiency and particle size. Further characterization was carried out using scanning electron microscopy (SEM), differential scanning calorimetry (DSC), In vitro release study and In vivo anti-ulcer activity.
Results: Fourier transform infrared (FTIR) study indicated compatibility between drug and polymer. DSC study revealed that the drug was molecularly dispersed in the polymer. The optimised batch showed 49.63Â±1.23% drug entrapment and 170.12Â±3.36 Î¼m particle size. SEM study showed that microspheres were spherical in shape. In vitro drug release study showed only 4.28Â±1.23% drug release in simulated gastric media in 2 hr and 93.46Â±1.20% release in simulated intestinal media after 1 hr from the optimised batch.
Conclusion: Results of in vitro release studies indicated the gastro-resistant nature of the developed microspheres. In vivo anti-ulcer activity demonstrated that EMT loaded microspheres were able to significantly reduce ethanol-induced ulcer formation in rats' stomach as compared to the aqueous solution of EMT. So it can be concluded that the developed gastro-resistant microspheres of EMT prevented drug release in the stomach which would lead to a significant improvement in its bioavailability through enhanced intestinal absorption
Banker GS, Anderson NR. Tablets: the theory and practice of industrial pharmacy. India: Varghese Pub. House: 2003. p. 197-242.
Ling SS, Magosso E, Khan NA, Yuen KH, Barker SA. Enhanced oral bioavailability and intestinal lymphatic transport of a hydrophilic drug using liposomes. Drug Dev Ind Pharm 2006;32:335-45.
Vyas SP, Khar RK. Targeted and controlled drug delivery novel carrier systems. New Delhi: CBS Publishers and distributors; 2004. p. 417-52.
Kemala T, Budianto E, Soegiyono B. Preparation and characterization of microspheres based on a blend of poly(lactic acid) and poly(e-caprolactone) with poly(vinyl alcohol) as an emulsifier. Arabian J Chem 2012;5:103â€“8.
Dent J. Pharmacology of esomeprazole and comparisons with omeprazole. Aliment Pharmacol Ther 2003;17 Suppl 1:5â€“9.
Anroop BR. Formulation and evaluation of enteric coated tablets of proton pump inhibitor. J Basic Clin Pharm 2010;1:215-21.
Stroyer A, McGinity JW, Leopold CS. Solid state interactions between the proton pump inhibitor omeprazole and various enteric coating polymers. J Pharm Sci 2006;95:1342-53.
Gohel MC, Amin AF. Formulation optimisation of controlled release diclofenac sodium microspheres using factorial design. J Controlled Release 1998;51:115â€“22.
Yandrapu S, Kompella UB. Development of sustained-release microspheres for the delivery of SAR 1118, an LFA-1 antagonist, intended for the treatment of vascular complications of the Eye. J Ocul Pharmacol Ther 2013;29:236-48.
Singh B, Mehta G, Kumar R, Bhatia A, Ahuja N, Katare OP. Design, development and optimisation of nimesulide-loaded liposomal systems for topical application. Curr Drug Delivery 2005;2:143â€“53.
Khan M, Ansari VA, Kushwaha P, Kumar A, Akhtar J. Mucoadhesive microspheres for controlled delivery of drugs. Asian J Pharm Clin Res 2015;8:1-20.
Fang Y, Wang G, Zhang R, Liu Z, Liu Z, Wu X, et al. Eudragit L/HPMCAS blend enteric-coated lansoprazole pellets: enhanced drug stability and oral bioavailability. AAPS PharmSciTech 2014;15:513-21.
Yoshida T, Lai TC, Kwon GS, Sako K. pH-and ion-sensitive polymers for drug delivery. Expert Opin Drug Delivery 2013;10:1497â€“513.
Palanisamy M, Khanam J. Cellulose-based matrix microspheres of prednisolone inclusion complex: preparation and characterization. AAPS PharmSciTech 2011;12:388-400.
Rajeshwar KK, Arya VJ, Ripudaman S. Development and evaluation of gastro-resistant microspheres of pantoprazole. Int J Pharm Pharm Sci 2010;2:112-6.
Comoglu T, Dogan A, Basci N. Development and in vitro evaluation of pantoprazole-loaded microspheres. Drug Delivery 2008;15:295-302.
Herrmann J, Bodmeier R. Biodegradable, somatostatin acetate containing microspheres prepared by various aqueous and non-aqueous solvent evaporation methods. Eur J Pharm Biopharm 1998;45:75â€“82.
Venkateswaramurthy N, Sambathkumar R, Vijayabaskaran M, Perumal P. Clarithromycin mucoadhesive microspheres for anti-helicobacter pylori therapy: formulation and in vitro evaluation. Int J Curr Pharm Res 2010;2:24-7.
Mahajan HS, Tatiya BV, Nerkar PP. Ondansetron loaded pectin based microspheres for nasal administration: In vitro and in vivo studies. Powder Technol 2012;221:168â€“76.
Patil SB, Sawant KK. Development, optimisation and in vitro evaluation of alginate mucoadhesive microspheres of carvedilol for nasal delivery. J Microencapsulation 2009; 26:432â€“43.
Gaur PK, Mishra S, Bajpai M. Formulation and evaluation of controlled-release of telmisartan microspheres: In vitro/in vivo study. J Food Drug Anal 2014;22:542-8.
Pandit V, Pai RS, Yadav V, Devi K, Surekha BB, Inamdar MN, et al. Pharmacokinetic and pharmacodynamic evaluation of floating microspheres of metformin hydrochloride. Drug Dev Ind Pharm 2013;39:117â€“27.
Sawant KK, Patel MH, Patel K. Cefdinir nanosuspension for improved oral bioavailability by media milling technique: formulation, characterization and in vitroâ€“in vivo evaluations. Drug Dev Ind Pharm 2016;42:758-6.
Rathor S, Ram A. Porous microsphere of 5 flouru uracil: a tool for site-specific drug delivery in gastric cancer. Int J Curr Pharm Res 2011;3:38-42.
Mennini N, Furlanetto S, Cirri M, Mura P. Quality by design approach for developing chitosan-Ca-alginate microspheres for colon delivery of celecoxib-hydroxypropyl-b-cyclodextrin-PVP complex. Eur J Pharm Biopharm 2012;80:67â€“75.
Raffin RP, ColomÃ© LM, Pohlmann AR, Guterres SS. Preparation, characterization, and in vivo anti-ulcer evaluation of pantoprazole-loaded microparticles. Eur J Pharm Biopharm 2006;63:198-204.
Singh S, Shanthi N, Mahato AK. Formulation and evaluation of metronidazole tableted microspheres for colon drug delivery. Asian J Pharm Clin Res 2016;9:398-403.
Patel KJ, Dharamsi A. Formulation development and optimisation of controlled release microspheres of Aceclofenac using response surface methodology. J Chem Pharm Res 2015;7:88-99.
Subbiah G, D sudheer K, B sandeep K, R Abhilash, P Shanthan B, Kvs P, et al. Controlled release formulation and evaluation of idarubicin microsphere using biodegradable hydrophilic and hydrophobic polymer mixtures. Asian J Pharm Clin Res 2010;3:179-82.
Pachuau L, Mazumder B. A study on the effects of different surfactants on Ethylcellulose microspheres. Int J PharmTech Res 2009;1:966-71.
Khare P, Jain SK. Influence of rheology of dispersion media in the preparation of polymeric microspheres through emulsification method. AAPS PharmSciTech 2009;10:1295-300.
Sharma M, Kohli S, Dinda A. In vitro and in vivo evaluation of repaglinide loaded floating microspheres prepared from different viscosity grades of HPMC polymer. Saudi Pharm J 2015;23:675â€“82.
Ahmed MM, El-Rasoul SA, Auda SH, Ibrahim MA. Emulsification/internal gelation as a method for preparation of diclofenac sodiumâ€“sodium alginate microparticles. Saudi Pharm J 2013;21:61â€“9.
Jelvehgari M, Hassanzadeh D, Kiafara F, Loveymia BD, Amiri S. Preparation and determination of drug-polymer interaction and in vitro release of mefenamic acid microspheres made of cellulose acetate phthalate and/or ethylcellulose polymers. Iran J Pharm Res 2011;10:457-67.
Deshmukh RK, Naik JB. The impact of preparation parameters on sustained release aceclofenac microspheres: a design of experiments. Adv Powder Technol 2015;26:244â€“52.
Patil S, Babbar A, Mathur R, Mishra A, Sawant K. Mucoadhesive chitosan microspheres of carvedilol for nasal administration. J Drug Targeting 2010;18:321â€“31.
http://www.usp.org/sites/default/files/usp_pdf/EN/USPNF/2011-02-25711DISSOLUTION.pdf. [Last accessed on 25 Aug 2016]
Mostafa HF, Ibrahim MA, Mahrous GM, Sakr A. Assessment of the pharmaceutical quality of marketed enteric coated pantoprazole sodium sesquihydrate products. Saudi Pharm J 2011;19:123â€“7.